Viewing Study NCT00059657

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-16 @ 6:36 AM
Study NCT ID: NCT00059657
Status: COMPLETED
Last Update Posted: 2006-05-19
First Post: 2003-04-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
Sponsor: Tanabe Pharma Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral Vascular Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ecraprost in lipid emulsion View
None CLI View
None peripheral, vascular View
None amputation View
None Angioplasty View
None by-pass View
None Critical Limb Ischemia due to peripheral arterial disease View